Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia 4Lymphoma, Non-Hodgkin 2Lymphoma 2Thalassemia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myeloproliferative Disorders 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Leukemia, Prolymphocytic 1Kidney Transplantation 1Kidney Neoplasms 1Hodgkin Disease 1Hematologic Neoplasms 1Hematologic Diseases 1Carcinoma, Renal Cell 1

Interventions

fludarabine 2Cyclophosphamide 2zanubrutinib 1pegfilgrastim 1obinutuzumab 1fludarabine phosphate 1Specimen Handling 1Resistance Training 1Radiotherapy 1Neuropsychological Tests 1Modafinil 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Injections 1Filgrastim 1Contrast Media 1Blood Specimen Collection 1Azacitidine 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, B-Cell × Alemtuzumab × Clear all
NCT00038883 2018-11-07

Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies

M.D. Anderson Cancer Center

Phase NA Terminated
19 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡